ATA868677A - Verfahren zur herstellung von neuen 5-(subst. phenyl)-oxazolidinonen und deren schwefel- analoga - Google Patents
Verfahren zur herstellung von neuen 5-(subst. phenyl)-oxazolidinonen und deren schwefel- analogaInfo
- Publication number
- ATA868677A ATA868677A AT868677A AT868677A ATA868677A AT A868677 A ATA868677 A AT A868677A AT 868677 A AT868677 A AT 868677A AT 868677 A AT868677 A AT 868677A AT A868677 A ATA868677 A AT A868677A
- Authority
- AT
- Austria
- Prior art keywords
- oxazolidinones
- subst
- phenyl
- new
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/16—Sulfur atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762655369 DE2655369A1 (de) | 1976-12-03 | 1976-12-03 | 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung |
| DE19772745320 DE2745320A1 (de) | 1977-10-05 | 1977-10-05 | 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung ii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA868677A true ATA868677A (de) | 1979-12-15 |
| AT357529B AT357529B (de) | 1980-07-10 |
Family
ID=25771221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT868677A AT357529B (de) | 1976-12-03 | 1977-12-05 | Verfahren zur herstellung von neuen 5-(subst. phenyl)-oxazolidinonen und deren schwefel- analoga |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5382777A (de) |
| AT (1) | AT357529B (de) |
| AU (1) | AU519994B2 (de) |
| CA (1) | CA1097657A (de) |
| CH (1) | CH635578A5 (de) |
| CS (1) | CS199694B2 (de) |
| DD (1) | DD133667A5 (de) |
| DK (1) | DK149850C (de) |
| FR (1) | FR2372814A1 (de) |
| GB (1) | GB1588639A (de) |
| GR (1) | GR64964B (de) |
| HU (1) | HU175676B (de) |
| IE (1) | IE46435B1 (de) |
| IL (1) | IL53520A (de) |
| IT (1) | IT1089341B (de) |
| LU (1) | LU78616A1 (de) |
| NL (1) | NL7713153A (de) |
| SE (1) | SE441446B (de) |
| SU (1) | SU888821A3 (de) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2701215C2 (de) * | 1977-01-13 | 1982-10-14 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Thiazolin-2-thionen |
| US4348393A (en) * | 1978-06-09 | 1982-09-07 | Delalande S.A. | N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones |
| DE3438839A1 (de) * | 1984-10-19 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | Pharmazeutische praeparate |
| HU215433B (hu) * | 1986-04-29 | 2000-05-28 | Pfizer Inc. | Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására |
| US5459145A (en) * | 1988-01-19 | 1995-10-17 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
| JPH01135098U (de) * | 1988-03-11 | 1989-09-14 | ||
| WO1991007177A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| US5461056A (en) * | 1992-05-08 | 1995-10-24 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| GB9212673D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
| GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
| GB9226830D0 (en) * | 1992-12-23 | 1993-02-17 | Celltech Ltd | Chemical compounds |
| US5622977A (en) * | 1992-12-23 | 1997-04-22 | Celltech Therapeutics Limited | Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same |
| GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| EP0738268B1 (de) * | 1993-12-22 | 2004-03-03 | Celltech R&D Limited | Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe |
| GB9326173D0 (en) * | 1993-12-22 | 1994-02-23 | Celltech Ltd | Chemical compounds and process |
| US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
| US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
| GB9412573D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412571D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526245D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526246D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9608435D0 (en) * | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9619284D0 (en) * | 1996-09-16 | 1996-10-30 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9622363D0 (en) * | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9625184D0 (en) * | 1996-12-04 | 1997-01-22 | Celltech Therapeutics Ltd | Chemical compounds |
| US6057329A (en) * | 1996-12-23 | 2000-05-02 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives |
| GB9705361D0 (en) | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9924862D0 (en) | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
-
1977
- 1977-11-28 SU SU772546252A patent/SU888821A3/ru active
- 1977-11-29 NL NL7713153A patent/NL7713153A/xx not_active Application Discontinuation
- 1977-12-01 IT IT30254/77A patent/IT1089341B/it active
- 1977-12-01 LU LU78616A patent/LU78616A1/xx unknown
- 1977-12-01 DD DD7700202354A patent/DD133667A5/de unknown
- 1977-12-01 SE SE7713635A patent/SE441446B/xx not_active IP Right Cessation
- 1977-12-02 IE IE2446/77A patent/IE46435B1/en not_active IP Right Cessation
- 1977-12-02 GR GR54913A patent/GR64964B/el unknown
- 1977-12-02 JP JP14492277A patent/JPS5382777A/ja active Granted
- 1977-12-02 CH CH1477977A patent/CH635578A5/de not_active IP Right Cessation
- 1977-12-02 AU AU31175/77A patent/AU519994B2/en not_active Expired
- 1977-12-02 IL IL53520A patent/IL53520A/xx unknown
- 1977-12-02 HU HU77SCHE632A patent/HU175676B/hu not_active IP Right Cessation
- 1977-12-02 GB GB50350/77A patent/GB1588639A/en not_active Expired
- 1977-12-02 DK DK536677A patent/DK149850C/da not_active IP Right Cessation
- 1977-12-02 CA CA292,273A patent/CA1097657A/en not_active Expired
- 1977-12-05 AT AT868677A patent/AT357529B/de not_active IP Right Cessation
- 1977-12-05 FR FR7736525A patent/FR2372814A1/fr active Granted
- 1977-12-05 CS CS778086A patent/CS199694B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LU78616A1 (de) | 1978-04-20 |
| IT1089341B (it) | 1985-06-18 |
| AU3117577A (en) | 1979-06-07 |
| DK149850B (da) | 1986-10-13 |
| HU175676B (hu) | 1980-09-28 |
| NL7713153A (nl) | 1978-06-06 |
| FR2372814B1 (de) | 1980-10-10 |
| SE7713635L (sv) | 1978-06-04 |
| IL53520A (en) | 1981-07-31 |
| GB1588639A (en) | 1981-04-29 |
| SE441446B (sv) | 1985-10-07 |
| IE772446L (en) | 1978-06-03 |
| IL53520A0 (en) | 1978-03-10 |
| GR64964B (en) | 1980-06-10 |
| SU888821A3 (ru) | 1981-12-07 |
| IE46435B1 (en) | 1983-06-15 |
| JPS5382777A (en) | 1978-07-21 |
| DK149850C (da) | 1987-04-27 |
| CH635578A5 (en) | 1983-04-15 |
| CA1097657A (en) | 1981-03-17 |
| DD133667A5 (de) | 1979-01-17 |
| CS199694B2 (en) | 1980-07-31 |
| DK536677A (da) | 1978-06-04 |
| AT357529B (de) | 1980-07-10 |
| AU519994B2 (en) | 1982-01-07 |
| FR2372814A1 (fr) | 1978-06-30 |
| JPS6154792B2 (de) | 1986-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATA868677A (de) | Verfahren zur herstellung von neuen 5-(subst. phenyl)-oxazolidinonen und deren schwefel- analoga | |
| AT385022B (de) | Verfahren zur herstellung von neuen poroesen, kristallinen, titan-modifizierten kieselsaeuren mitsilicalithgefuege | |
| ATA361576A (de) | Verfahren zur herstellung von neuen, substi- tuierten 4-methyl-5-imidazolyl- und 2-thia- zolylguanidinen | |
| ATA348877A (de) | Verfahren zur herstellung von neuen n- acylierten | |
| AT349634B (de) | Verfahren zur herstellung von neuen anthra- cyclinglycosiden | |
| ATA245275A (de) | Verfahren zur herstellung von neuen 1,1-diaryl-1-oxadiazolalkylaminen | |
| AT348535B (de) | Verfahren zur herstellung von neuen 1,2- dithiolderivaten | |
| AT349028B (de) | Verfahren zur herstellung von neuen 1,2- dithiolderivaten | |
| AT352279B (de) | Verfahren zur herstellung von neuen rifamyzin- verbindungen | |
| AT354443B (de) | Verfahren zur herstellung von neuen oxazol- bzw. thiazolderivaten | |
| ATA303477A (de) | Verfahren zur herstellung von neuen indazolyl- (4-)-oxy-propanolaminen | |
| AT351675B (de) | Verfahren zur herstellung von neuen clavulan- saeurethioaethern | |
| ATA53777A (de) | Verfahren zur herstellung von neuen indolinospiropyranverbindungen | |
| AT357693B (de) | Verfahren zur herstellung von neuen ergolen- -derivaten | |
| AT343095B (de) | Verfahren zur herstellung von neuen 2,6-dinitro-3-azido-4-trifluormethylanilinen und -hydrazinen | |
| AT352280B (de) | Verfahren zur herstellung von neuen rifamyzin- verbindungen | |
| AT353411B (de) | Verfahren zur herstellung von neuen 4- -dedimethylamino-4-arylsulfonamido-5a,6- -anhydrotetracyclinen | |
| ATA577177A (de) | Verfahren zur herstellung von neuen optisch aktiven derivaten des d-threo-1-phenyl-2- trifluoracetamidopropandiols-(1,3) | |
| ATA425783A (de) | Verfahren zur herstellung von neuen n1-(2-cyano-2-methoxy- bzw. hydorxy-imino)acetyl-n2-cycloalkylharnstoffen | |
| AT358189B (de) | Verfahren zur herstellung von neuen aspidosper- midinen | |
| DD132497A1 (de) | Verfahren zur herstellung von neuen gona-4,9(10)-dienen | |
| AT351558B (de) | Verfahren zur herstellung von neuen 2-formyl- amino-phenylguanidinen | |
| AT356301B (de) | Verfahren zur herstellung von neuen d-homo- steroiden | |
| ATA568078A (de) | Verfahren zur herstellung von neuen benzylcyanoacetalen | |
| ATA226977A (de) | Verfahren zur herstellung von neuen 5-fluor- dihydrouracilen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |